The FDA Wants this Highly Addictive Opioid Taken off the Market

On June 8, 2017, the FDA requested that the drug-maker Endo Pharmaceuticals stop selling Opana ER – the extended-release version of Opana – because of “public health consequences of abuse.” It is the first time the agency has made efforts to pull an opioid from the market due to its highly addictive nature. [1] According […]

Marijuana Strain Recalled in Oregon over High Pesticide Levels

The Oregon Liquor Control Commission (OLCC) issued its first-ever marijuana recall after samples of Blue Magoo marijuana were found to contain a level of pesticide residue that exceeds the state’s limit. The cannabis brand is sold at a Mapleton, Oregon, store. [1] Source: Oregon Cannabis Connection The OLCC, which oversees retail sales of recreational marijuana, […]